What Researchers Did
Researchers presented a case report detailing the treatment of a 47-year-old premenopausal woman with end-stage breast cancer using metabolically supported chemotherapy, a ketogenic diet, hyperthermia, and hyperbaric oxygen therapy.
What They Found
The abstract describes the patient's journey, including her initial refusal of conventional chemotherapy, subsequent disease progression, and eventual ineligibility for standard treatments due to advanced disease and poor health. She then received the described combined therapy at the ChemoThermia Oncology Center in Istanbul, Turkey. While the study title indicates a "complete and durable response," the provided abstract text concludes before detailing the specific outcomes of this treatment.
What This Means for Canadian Patients
This single case report explores a multi-modal approach for advanced breast cancer, potentially offering insights for patients with limited conventional treatment options. However, as a case study, it does not provide generalizable evidence for Canadian patients, and extensive clinical trials are required to establish the efficacy and safety of this combined therapy.
Canadian Relevance
No direct Canadian connection identified. Hyperbaric oxygen therapy for breast cancer is not a Health Canada-recognized indication.
Study Limitations
This is a single case report, which inherently limits generalizability, and the provided abstract does not detail the specific outcomes of the treatment.